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Neglected Diseases
S
epsis is a progressive injurious process resulting from 
a systemic inflammatory response to infection [1]. 
In developed countries, sepsis is an important cause 
of mortality: in the United States alone, up to 750,000 
people annually suffer from severe sepsis—mostly bacterial 
in aetiology—of whom 29% may die [2,3]. Unfortunately, 
data on bacterial sepsis in developing countries are notably 
lacking, particularly in adults. Estimates of the burden of 
lower respiratory tract infections, meningitis, and “other 
infections”, of which a significant proportion are associated 
with severe sepsis, show that the majority of deaths and 
disability-adjusted life years lost occur in low-income 
countries (Figure 1) [4]. Additionally, severe sepsis is likely 
to complicate a varying proportion of cases of malaria, HIV/
AIDS, diabetes, maternal conditions, and cancer deaths 
globally.
The standard of care varies significantly across lower- and 
middle-income developing countries, but published reports 
suggest that outcomes are poor even at major hospitals 
[5–10]. Melioidosis, a serious tropical infection caused by 
Burkholderia pseudomallei that often presents with sepsis, is 
endemic in a region containing both high- and low-income 
countries [11]. Outcomes vary significantly: the case fatality 
rate for melioidosis is higher in Thailand (40%–50%) than 
in Australia (10%–20%) [11–13], and the case-fatality rate 
for melioidosis with severe sepsis is approximately 50% in 
Singapore compared with 90% in a Thai clinical trial [14,15]. 
The burden of disease and case fatality of patients with 
melioidosis in less developed countries such as Cambodia and 
Myanmar are unknown. Although melioidosis is not common 
outside of southeast Asia, extrapolating this experience 
suggests that the outcomes from all-cause bacterial sepsis in 
underdeveloped regions are likely to be poor. 
The recently updated “Surviving Sepsis Campaign” 
guidelines have been widely disseminated in the developed 
world as a model of optimal sepsis management [16]. 
Although there has been some controversy regarding 
the recommendations and the development of the 
guidelines [17–19], most interventions based on 
improving early management of septic patients are less 
controversial. Crucially, most of the studies on which 
these recommendations are based were undertaken in the 
developed world and may not be applicable to the majority 
of the world’s population who live in poorer regions. 
The purpose of this paper is to highlight the paucity of 
epidemiological or management data on bacterial sepsis 
in the developing world, discuss current management 
approaches to sepsis in adults, and examine how clinical 
sepsis management guidelines could be best adapted to 
provide improved care at low cost in under-resourced regions. 
We use the term “developing country” to refer to lower- or 
middle-income countries as defined by the World Bank [20]. 
Identification of Sepsis
Interventions performed soon after diagnosis of sepsis in 
developed regions have been shown to improve survival 
[21,22], and in developing countries, interventions to identify 
Strategies to Reduce Mortality from Bacterial 
Sepsis in Adults in Developing Countries
Allen C. Cheng, T. Eoin West, Direk Limmathurotsakul, Sharon J. Peacock*
Funding: ACC is supported by a Health Professional Research Fellowship from 
the Australian National Health and Medical Research Council. TEW is funded by 
National Institutes of Health grant U54AI057141. SJP is supported by the Wellcome 
Trust. The funding bodies played no role in the decision to submit the article or in 
its preparation.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Cheng AC, West TE, Limmathurotsakul D, Peacock SJ (2008) Strategies to 
reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 
5(8): e175. doi:10.1371/journal.pmed.0050175
Copyright: © 2008 Cheng et al. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original author 
and source are credited.
Allen C. Cheng is with the Department of Medicine, University of Melbourne, 
and the Menzies School of Health Research, Charles Darwin University, Darwin, 
Northern Territory, Australia. T. Eoin West is with the Department of Medicine, 
Harborview Medical Center, University of Washington, Seattle, Washington, United 
States of America. Direk Limmathurotsakul and Sharon J. Peacock are with the 
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, 
Mahidol University, Bangkok, Thailand. Sharon J. Peacock is also with the Centre 
for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical 
Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom. 
* To whom correspondence should be addressed. E-mail: sharon@tropmedres.ac
The Neglected Diseases section focuses attention either on a specific disease or 
describes a novel strategy for approaching neglected health issues in general.
Summary Points
sÈ 4HEÈBURDENÈOFÈSEPSISÈISÈUNDERSTUDIEDÈBUTÈLIKELYÈTOÈBEÈHIGHÈINÈ
developing countries.
sÈ -OSTÈPREVIOUSÈSTUDIESÈHAVEÈBEENÈDISEASE
SPECIFICÈRATHERÈTHANÈ
syndrome-focused.
sÈ 4HEÈRECENTLYÈUPDATEDÈh3URVIVINGÈ3EPSISvÈGUIDELINESÈHAVEÈ
defined the standard of care for patients with severe sepsis in 
the developed world but do not incorporate the realities of 
health care in resource-constrained settings.
sÈ !ÈFOCUSÈONÈEARLYÈMANAGEMENTÈOFÈSEVEREÈSEPSISÈINCLUDINGÈFLUIDÈ
management, blood pressure control, timely administration 
of antibiotics, and source control, is likely to be the most 
cost-effective intervention for critically ill, septic patients 
in resource-constrained settings. The efficacy of particular 
strategies of care needs to be evaluated in clinical studies.
sÈ !NÈINTEGRATEDÈPROGRAMMEÈOFÈMANAGEMENTÈFORÈADULTSÈWHICHÈ
includes training for health care workers on the prevention, 
recognition, and management of severe sepsis, is required. PLoS Medicine  |  www.plosmedicine.org 1174 August 2008  |  Volume 5  |  Issue 8  |  e175
and treat pneumonia in children reduce mortality [23]. Thus, 
prompt identification of sepsis in developing countries is an 
essential component of any management strategy. Most studies 
of infection have focused on specific diseases, but sepsis itself 
is a clinically recognisable syndrome despite its heterogeneous 
causes. From a practical standpoint, sepsis is largely a clinical 
diagnosis [24], and implementation of strategies to promote 
recognition of sepsis as a clinical syndrome should be feasible 
even in the most resource-challenged areas where supportive 
radiographic imaging or laboratory measurements are not 
available. Education of health care providers about sepsis is 
critical to enhance the early identification of sick patients and 
may help facilitate transfer to available health care facilities. 
Simple algorithms tailored to local medical capacities that 
comprise the basic components of sepsis, such as diagnosed 
or suspected infection and the systemic manifestations of 
infection, may be useful.
Initial Treatment of Sepsis
Volume resuscitation is a well-established initial therapy of 
sepsis. Many studies have demonstrated that tissue perfusion 
in sepsis is partly impaired by hypovolaemia [25,26], and 
patients may have substantial fluid deficits requiring 6–10 
l within the first 24 hours [21,27]. Guidelines suggest that 
hypotensive patients should receive an initial challenge of 20 
ml/kg or boluses of 500–1000 ml of crystalloid with ongoing 
monitoring of volume status [16,28,29]. Observational 
evidence suggests that aggressive fluid resuscitation was 
associated with decreased early mortality from typhoid with 
ileal perforation in a rural African hospital [30]. 
Although albumin is at least as effective as crystalloids for 
volume resuscitation in sepsis, the latter is cheaper and more 
widely available [31]. Judicious enteral fluid loading with 
standard oral rehydration solution has been used in other 
forms of hypovolaemia, but is as yet untested as a strategy 
in sepsis [32,33]. In severely compromised patients, oral 
fluids may be associated with a risk of pulmonary aspiration 
and are less likely to be effective with severe intravascular 
hypovolaemia. Invasively measured endpoints of fluid 
resuscitation have been defined [28], but clinical endpoints 
such as blood pressure and heart rate measurements, skin 
colour and capillary refill, mental status, or urinary output are 
the most feasible measures for monitoring in underdeveloped 
regions. Central venous access, where available, may be 
helpful for monitoring of central venous pressure and 
administration of vasopressors. Simpler non-invasive devices 
such as tissue perfusion monitors may be more practical but 
are not yet used widely [33]. 
Because septic shock is often characterised by 
inappropriate peripheral vasodilation, initiation of 
vasopressor therapies is indicated for persistent hypotension 
following fluid loading [16,34]. Although norepinephrine 
and (supra-renal dose) dopamine are accepted first-line 
agents [16,28], both may be associated with extravasation-
related tissue necrosis if infused into a peripheral vein when 
central venous access is not possible. Accurate titration of 
intravenous vasopressors is also problematic in the absence 
of infusion pumps. Finally, non-invasive monitoring of 
blood pressure may be less accurate than intra-arterial 
blood pressure monitoring [16]. We have identified very few 
studies of non-intravenous vasopressor agents, such as oral 
midodrine [35], yet conceivably such therapies may play a 
role in sepsis management when intravenous medications are 
not feasible. 
doi:10.1371/journal.pmed.0050175.g001
Figure 1. Mortality and Disability-Adjusted Life Years (DALYs) Lost in Adults 15–60 Years Old in 2002 for Three Selected Indicator Diseases, by 
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Haemodynamic optimisation measures in the resuscitation 
of ill septic patients often require extensive nursing and 
medical resources. An invasive goal-directed haemodynamic 
optimisation therapy approach to early sepsis management, 
while effective, has proven challenging to implement even 
in large hospitals in the United States, and is not practical 
to consider in this form for health care facilities in most 
developing settings [21,36]. Nonetheless, in regions 
where basic sepsis therapies exist yet early management is 
suboptimal, enhanced care could be achieved with simple, 
clearly defined fluid resuscitation and blood pressure 
management protocols, incorporating clinical endpoints and 
non-invasive tools if available. In areas where paramedical 
staff are available, simply engaging an assistant to observe 
patient status may be a cost-effective substitute for electronic 
monitoring. In better staffed facilities, designation of a 
dedicated nurse for at least the initial resuscitation period 
may be beneficial. However, more studies are required to 
determine optimal fluid resuscitation strategies where invasive 
haemodynamic monitoring and fall-back therapies (such as 
mechanical ventilation and dialysis) may not be available.
Antibiotic Regimens
The timely and appropriate use of antibiotics in the 
early management period is associated with survival from 
sepsis and pneumonia [22,37]. A potential barrier to the 
formulation of an effective empiric antimicrobial regimen 
is that the spectrum of bacterial pathogens in the tropics is 
often diverse. In one study in Kenyan children, 16 individual 
pathogens, each of which accounted for less than 10% 
of cases, accounted for over a third of bacteraemias [38]. 
Similarly, in a study of adults in Nepal, no single pathogen 
accounted for more than 13% of patients where a pathogen 
was identified [39].
Many regions do not have access to diagnostic microbiology 
laboratories, so the causes of sepsis and their susceptibility 
profiles may not be known. The list of common bacterial 
pathogens may also show significant variation, even between 
neighbouring countries. An example of this is between 
the adjacent countries of Thailand and Laos. In northeast 
Thailand, common causes of community-acquired sepsis 
include Staphylococcus aureus, pneumococci and other 
streptococci, Escherichia coli and other Enterobacteriaceae, 
Pseudomonas spp., and B. pseudomallei [40], as well as 
leptospirosis, scrub typhus, and dengue [41]. In adjacent 
Vientiane, Laos, the commonest cause of community-
acquired bacteraemia in one study was Salmonella enterica 
serovar typhi (50.9%), followed by S. aureus and E. coli 
[42]. Causes of hospital-acquired sepsis are also poorly 
characterised in resource-constrained settings where culture 
facilities are limited or absent, but lack of infection control 
infrastructure is likely to be associated with a significant 
burden of nosocomial sepsis. Because improved outcomes 
in sepsis management depend on early and appropriate 
antibiotic administration, it is critical that these issues be 
addressed in future epidemiological studies.
The role of the clinical microbiology laboratory in 
developing countries has been discussed extensively 
elsewhere, and issues relating to problems with clinical 
misdiagnosis, poor use of existing resources, and quality 
assurance are well documented [43,44]. Possible solutions 
include the development of low-cost laboratories, or the 
intermittent use of mobile diagnostic “clinics” that can define 
the range of pathogens and their susceptibility patterns in a 
given area to inform a rational empiric prescribing policy. 
These data should be widely disseminated to clinicians within 
the region. Evidence for the impact on mortality of accurate 
diagnosis can be seen from mortality rates from melioidosis 
in northeast Thailand over time. The burden of melioidosis 
became apparent after diagnostic laboratories were 
introduced into this area in the early 1970s [45]. This led to 
the first clinical treatment trial that reported a reduction in 
mortality from 74% to 37% for patients with acute melioidosis 
treated with ceftazidime compared with the previous 
combination antibiotic therapy [46]. Similarly, recent clinical 
trials have been prompted by the recognition of emerging 
resistance in Salmonella typhi [47].
There are a number of concerns with respect to antibiotic 
therapy in developing regions. In many developing countries, 
antibiotics are not regulated and are freely available, 
particularly in urban areas. It is becoming widely appreciated 
that a significant proportion of patients in rural Asia will 
have taken antibiotics prior to presentation to hospital 
[48,49]. This has major implications both for antibiotic 
resistance and the sensitivity of diagnostic culture when 
the patient presents to hospital. The quality of antibiotics 
is a further consideration. Fake drugs are widespread in 
the tropics [50] and have been implicated in deaths from 
malaria. Furthermore, many antibiotics are stored at room 
temperature, but ambient temperatures may reach 40° C in 
the tropics. 
Supportive and Adjunctive Therapeutic Agents
Prophylaxis for deep venous thrombosis and for peptic 
“stress” ulcers can be readily implemented in many 
developing countries. Histamine blockers such as ranitidine 
are inexpensive and can be administered via nasogastric 
Five Key Papers in the Field
Dellinger et al., 2008 [16] These international guidelines detail 
the current standard of care for patients with severe sepsis in 
developed countries.
Cheng et al., 2007 [15] This trial demonstrated poor outcomes 
from septic shock due to suspected melioidosis despite 
hospital care in Thailand, with in-hospital mortality exceeding 
80%. Granulocyte colony stimulating factor, as an adjuvant to 
antibiotics, was not associated with a mortality benefit.
Phu et al., 2002 [63] This trial in Vietnam demonstrated that 
haemodialysis was more effective than peritoneal dialysis in 
patients with infection-related acute renal failure predominantly 
due to malaria. Despite the increased cost, the mortality benefit 
was large, suggesting that haemodialysis was more cost-
effective.
Rivers et al., 2001 [21] This single-centre randomised controlled 
trial demonstrated a 16% absolute decrease in in-hospital 
mortality associated with early goal-directed management 
compared with standard management.
Gove S, 1997 [73] This paper describes the development and 
evaluation of the integrated management of childhood illness 
guidelines and training course for health workers in developing 
countries.PLoS Medicine  |  www.plosmedicine.org 1176 August 2008  |  Volume 5  |  Issue 8  |  e175
tube to intubated patients. Although some have argued 
that the incidence of venous thromboembolism is lower 
in populations of non-European origin [51–53], more 
recent evidence suggests that this may not be the case in 
post-operative and medical patients [54,55]. In the absence 
of studies in critically unwell patients with prolonged 
immobilisation, the use of subcutaneous unfractionated 
heparin seems warranted. 
Other interventions often used in the developed setting 
for patients with severe sepsis are renal replacement therapy 
and mechanical ventilation. Respiratory failure is a frequent 
complication of severe sepsis, and progression to acute lung 
injury is most commonly caused by sepsis [56,57]. In a trial 
of granulocyte colony stimulating factor in severe sepsis due 
to melioidosis in Thailand [15], 70% of patients required 
intubation and ventilation. Where available, mechanical 
ventilation of septic patients in developing countries is 
associated with extremely high mortality rates [6], and in 
some countries, patients with respiratory failure are ventilated 
by hand by relatives (A. C. Cheng, personal experience). 
Many ventilators in developing countries are simple devices 
that do not have minute ventilation alarms or allow for 
adjunct ventilator functions such as positive end-expiratory 
pressure. Sub-optimal ventilator care may lead to ventilator-
associated pneumonia [58,59], and the lack of low-volume 
“lung-protective” strategies may be associated with poor 
outcomes from acute lung injury [60]. The reliance on non-
invasive monitoring using peripheral oxygen saturation may 
reduce the ability to monitor the adequacy of ventilation. 
Although non-invasive positive-pressure ventilation is mainly 
used for respiratory failure in non-septic patients, it has 
been used successfully in developing countries [61,62], 
and strategies incorporating non-invasive positive-pressure 
ventilation should be evaluated further where invasive 
mechanical ventilation cannot be managed adequately. 
The cost of equipment and trained staff largely prohibits 
the use of renal replacement therapies in low-income settings, 
although they are used to a variable extent in rural regions 
of middle-income countries. In Vietnam, haemofiltration 
was more cost-effective than peritoneal dialysis in infection-
related renal failure despite its significant cost [63]. This 
study primarily included patients with malaria, but such a 
study would be of significant interest in patients with sepsis 
in resource-constrained settings where haemofiltration is 
possible. In a study of severe sepsis in melioidosis, acute renal 
failure and acidosis were prominent on admission, suggesting 
that aggressive fluid resuscitation and/or renal replacement 
therapy would be potentially beneficial in this group [15]. 
There has been increasing awareness of the importance 
of acidosis and fluid and electrolyte imbalances in severe 
malaria, and despite differences in pathophysiology, such 
research may be relevant to severe bacterial sepsis [64,65]. 
There have been few trials of adjuvant therapies in 
developing countries, and results of studies may not be 
generalisable to this setting. For example, granulocyte colony 
stimulating factor appeared to be associated with significant 
benefit in treating melioidosis in Australia [13], but was not 
associated with a significant mortality benefit in Thailand 
in a clinical trial [15]. Conversely, high-dose steroids are 
not thought to be useful in severe sepsis generally, but may 
possibly have a specific application in severe typhoid [66–68]. 
Interventions that are of marginal benefit in developed 
countries, such as physiological dose steroid replacement 
[19,69] or intensive insulin therapy, are unlikely to be 
effective in developing countries in the absence of other 
standard intensive care interventions. The risk of adverse 
events, such as hypoglycaemia, associated with intensive 
insulin regimens are likely be greater in resource-poor 
settings, and the setting of less strict blood glucose targets 
may be warranted [16,18,70]. However, the safety and efficacy 
of such strategies require study. The effectiveness of activated 
protein C (drotrecogin alfa) has also been subject to intensive 
debate, but the cost of this therapy is prohibitive for most 
health care systems in developing countries [71,72]. 
Training
Implicit in this discussion is the need for appropriately 
trained health care providers at the local level. Ideally, sepsis 
identification and management training should be integrated 
into general adult health care. Such a strategy is analogous 
to the World Health Organization’s Integrated Management 
of Childhood Illness training course, which included severe 
infection, chronic diseases, and preventative measures for all 
levels of health workers including doctors, nurses, medical 
assistants, and literate paramedical workers at both a primary, 
and more recently, hospital level [73,74]. This course was 
integrated into a comprehensive strategy that also included 
measures to improve drug supply, health care infrastructure, 
and family behaviour in relation to sick children. 
Cost-Effectiveness
The development of critical care services has significant 
resource implications for developing countries. We propose 
a stepwise approach based on income level, from extremely 
limited services in Africa and parts of southeast Asia, to more 
extended services in lower-middle-income countries such 
as Thailand and some South American countries (Table 1). 
Some evidence suggests that critical care services may be cost-
effective even in poor countries, but such a decision needs 
to be made on a case-by-case basis [75]. We feel that with 
the current paucity of evidence regarding the effectiveness 
of potential interventions for severe sepsis, such decisions 
cannot currently be made. We further note that factors 
other than cost-effectiveness must be considered in priority 
setting in health care resource allocation, including equity, 
ethical, and political considerations [76]. However, where 
such services already exist, the challenge is to integrate these 
into the broader health care system to ensure access and to 
provide a cost-effective and sustainable staffing model [77]. 
Further research is required to define the most effective 
interventions for sepsis in developing countries, as well as 
evaluation and quality control programmes for existing 
services. 
Prevention
Few vaccines are available against most of the common 
causes of severe sepsis in the tropics, and many vaccines 
with known substantial efficacy against common diseases 
such as typhoid and pneumococcal disease are not generally 
available to developing countries because of cost. Other 
preventative measures may be useful for specific diseases. 
In a case-control study in northeast Thailand, the use of 
protective clothing reduced the incidence of leptospirosis 
[78], and protective footwear may also help prevent PLoS Medicine  |  www.plosmedicine.org 1177 August 2008  |  Volume 5  |  Issue 8  |  e175
Table 1. Possible Interventions for the Management of Sepsis in Resource-Constrained Settings
Issue Management Where 
Few Resources Are 
Available
Management Where Some 
Resources Are Available
Considerable Resources 
Available, But Less Than in 
Developed Countries
Standard of Care in 
Developed Countries
Example of setting Community health station sÈ Community hospital sÈ Provincial hospital, middle-income  sÈ
countries
Referral centre, developed  sÈ
countries
Strategy Early recognition and  sÈ
treatment of sepsis
Referral to centre with   sÈ
basic supportive care  
where possible
Early recognition and treatment   sÈ
of sepsis 
Referral to centre with basic  sÈ
supportive care where possible
Early recognition and management   sÈ
of sepsis and treatment of disease
Referral to centre with more  sÈ
advanced supportive care where 
required
Early recognition and  sÈ
management of sepsis and 
treatment of disease
Rapid diagnosis with  sÈ
advanced supportive care
Initial assessment Recognition of sepsis  sÈ
syndrome
Recognition of sepsis and severe  sÈ
sepsis syndromes, basic  
assessment of organ dysfunction
Recognition of sepsis and severe  sÈ
sepsis syndromes, comprehensive 
assessment of organ dysfunction
Recognition of sepsis and  sÈ
severe sepsis syndromes, 
comprehensive assessment of 
organ dysfunction
Antibiotic therapy Prompt oral (+/− parenteral)  sÈ
antibiotic management to 
cover common causes of 
sepsis
Prompt empiric antibiotic   sÈ
treatment to cover common  
causes of sepsis 
Gram stain to guide antibiotic  sÈ
management
Prompt empiric antibiotic   sÈ
treatment to cover common  
causes of sepsis 
Specimen culture (+/− advanced  sÈ
diagnostics at regional reference 
laboratories)
Prompt (within <1 hour)  sÈ
empiric antibiotic treatment 
to cover common causes of 
sepsis
Diagnostics (including  sÈ
invasive specimen sampling, 
use of rapid tests) to guide 
antibiotic management
Source control Clinical assessment and  sÈ
referral as appropriate
Clinical assessment of deep foci   sÈ
of infection +/− drainage
Clinical assessment and imaging,   sÈ
with surgical or radiologically  
guided drainage
Clinical assessment and  sÈ
imaging for deep foci of 
infection with drainage
Fluid therapy Oral fluid administration sÈ Fluid challenge (>20 ml/kg) if  sÈ
hypotensive
Fluid management guided by   sÈ
clinical assessment of volume  
status
Electrolyte monitoring and  sÈ
replacement where possible
Fluid challenge if hypotensive sÈ
Fluid management guided by   sÈ
central venous monitoring
Electrolyte monitoring and  sÈ
replacement
Fluid challenge if hypotensive sÈ
Fluid management guided by  sÈ
central venous monitoring
Electrolyte monitoring and  sÈ
replacement
Later conservative fluid  sÈ
strategy if ARDS present
Vasopressors and 
inotropes
Refer if required, where  sÈ
possible
Dopamine to maintain MAP >65  sÈ
mmHg after fluid challenge
Continuous arterial pressure  sÈ
monitoring
Norepinephrine or dopamine   sÈ
(+/− inotropes) if central venous 
infusions can be administered
Continuous arterial pressure  sÈ
monitoring
Norepinephrine or dopamine  sÈ
(+/− inotropes) via central 
venous catheter
Ventilatory support Supplemental oxygen   sÈ
where available
Support guided by clinical  sÈ
assessment and SpO2
Mechanical ventilation sÈ
Arterial blood gas monitoring sÈ
More complex ventilation strategies  sÈ
(PEEP, low-volume lung-protective 
ventilation if indicated)
Non-invasive ventilation sÈ
Arterial blood gas monitoring sÈ
PEEP sÈ
Low-volume lung-protective  sÈ
ventilation if indicated
Weaning protocol sÈ
Non-invasive ventilation sÈ
Sedation Analgesia where available sÈ For ventilated patients, regular  sÈ
administration of sedatives with 
dosing according to protocol  
based on sedation scale
For ventilated patients, intermittent  sÈ
or continuous dosing of sedatives 
according to protocol based on 
sedation scale
For ventilated patients,  sÈ
intermittent or continuous 
dosing of sedatives according 
to protocol based on sedation 
scale
Renal replacement 
therapy
Refer if required, where  sÈ
possible
Peritoneal dialysis sÈ Intermittent haemodialysis   sÈ
or CVVHF 
Intermittent haemodialysis or  sÈ
CVVHF if unstable
Other management 
recommendations
Stress ulcer prophylaxis sÈ
DVT prophylaxis sÈ
Basic glycaemic control   sÈ
(<200 mg/l)
Stress ulcer prophylaxis sÈ
DVT prophylaxis sÈ
Glycaemic control (180–200 mg/l) sÈ
Stress ulcer prophylaxis sÈ
DVT prophylaxis sÈ
Glycaemic control (~150  sÈ
mg/l) using insulin infusion
Use of activated protein C for  sÈ
patients at high risk of death
Use of physiological dose  sÈ
steroids for refractory shock
Other issues Public awareness and  sÈ
prevention 
Staffing and training sÈ
Integration of critical care services  sÈ
into health system
Basic staffing and training sÈ
Public awareness and prevention sÈ
Research and evaluation sÈ
Medical/specialist supervision   sÈ
´ÈhCLOSEDvÈINTENSIVEÈCAREÈ 
model)
Specialist nursing training sÈ
h#LOSEDvÈINTENSIVEÈCAREÈMODEL sÈ
High staff–patient ratio  sÈ
Specialist medical and  sÈ
nursing training
ARDS, acute respiratory distress syndrome; CVVHF, continuous veno-venous haemofiltration; DVT, deep venous thrombosis; MAP, mean arterial pressure; PEEP, positive end-expiratory 
pressure; SpO2, saturation of oxygen in arterial blood flow.
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melioidosis, scrub typhus, snake bite, and physical injury. 
Although anecdotal reports suggested that farmers found 
protective footwear uncomfortable, particularly during 
the ploughing and planting seasons (V. Wuthiekanun, 
personal communication), it is possible that this obstacle 
could be overcome through a combination of education 
and the development of comfortable and practical clothing. 
Predictive modelling has proven to be a useful tool in malaria 
control [79], and similar techniques have been developed 
for a variety of other diseases such as cholera [80] and 
arboviruses [81]. Such tools might allow for targeting of 
public health interventions that may reduce exposure or 
disease transmission in specific populations.
Conclusion
The burden of sepsis is greatest in developing countries, and 
there is a need to translate modern management strategies 
for adults with severe sepsis to this context. The majority of 
studies of infectious diseases to date have been pathogen-
specific, but efforts are required to define the epidemiology 
of all-cause sepsis in developing countries and to define the 
most cost-effective interventions that are sustainable in these 
countries. Principles of management may be adapted from 
current guidelines, particularly low-cost interventions targeted 
at early sepsis. Critical care services need to be considered in 
the context of competing priorities for resource allocation, 
but where they currently exist, standardised protocols need to 
be developed and evaluated to make the best use of available 
resources.
Access to diagnostic facilities is fundamental to the care of 
the individual and to the development of logical and effective 
empiric prescribing regimens. Low-income countries rarely 
have access to diagnostic laboratories, and this is a major 
impediment to the improvement of care. Primary prevention 
is theoretically possible for a range of serious tropical 
infections, and studies are required to define acceptable 
measures and to validate their effectiveness.  
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